Literature DB >> 7545539

Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice.

S Tamir1, T deRojas-Walker, A Gal, A H Weller, X Li, J G Fox, G N Wogan, S R Tannenbaum.   

Abstract

SJL mice spontaneously develop B cell lymphomas (historically described as reticulum cell sarcomas) by 12 months of age and inflammatory muscle disease (myositis) by 6 months of age. Tumors originate in mesenteric lymph nodes and in Peyer's patches and resemble human germinal center lymphomas. The growth of reticulum cell sarcomas is completely dependent on cytokine production by normal T cells. The spontaneous myositis, which resembles human idiopathic myositis, is characterized by various abnormalities in skeletal muscle, including infiltration with inflammatory cells consisting primarily of macrophages. The participation of different cytokines in the pathogenesis of the lymphoma and the massive invasion of macrophages into muscle tissues led us to investigate the possible involvement of nitric oxide (NO.), which is known to be synthesized by activated macrophages under inflammatory conditions. Elevated NO. production, measured by urinary nitrate excretion, by SJL mice in comparison with BALB/c control mice was observed as early as 7 weeks of age. Both aging and degree of spontaneous myositis correlated with increased nitric oxide production. Oral administration of N-monomethyl-L-arginine, an inhibitor of nitric oxide synthase (NOS), reduced urinary nitrate excretion and also the severity of myositis. Immunohistochemical analysis revealed the presence of inducible NOS (iNOS) in cells in the spleen, lymph nodes, and skeletal muscle. The iNOS is primarily responsible for the enhanced nitric oxide production. Morphology of cells that stained positive for iNOS was similar to that of macrophages infiltrating into the affected tissues. Chronic production of elevated amounts of nitric oxide by the SJL mice, therefore, provides a useful in vivo model for future studies of cellular damage resulting from endogenously produced NO.in combination with oxygen radicals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545539

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  New insights into the functional role of the rheumatoid arthritis shared epitope.

Authors:  Denise E de Almeida; Song Ling; Joseph Holoshitz
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

2.  Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer.

Authors:  Jian Wang; Shouhui Yang; Peijun He; Aaron J Schetter; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Matthias M Gaida; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Clin Cancer Res       Date:  2016-07-08       Impact factor: 12.531

3.  Nitric oxide production in SJL mice bearing the RcsX lymphoma: a model for in vivo toxicological evaluation of NO.

Authors:  A Gal; S Tamir; S R Tannenbaum; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 4.  Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.

Authors:  Stefan Ambs; Sharon A Glynn
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

5.  Mutagenesis associated with nitric oxide production in transgenic SJL mice.

Authors:  A Gal; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 6.  A role for calreticulin in the pathogenesis of rheumatoid arthritis.

Authors:  Joseph Holoshitz; Denise E De Almeida; Song Ling
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.

Authors:  Christine A Kostek; Janice A Dominov; Jeffrey Boone Miller
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 8.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09

9.  Increased levels of inosine in a mouse model of inflammation.

Authors:  Erin G Prestwich; Aswin Mangerich; Bo Pang; Jose L McFaline; Pallavi Lonkar; Matthew R Sullivan; Laura J Trudel; Koli Taghizedeh; Peter C Dedon
Journal:  Chem Res Toxicol       Date:  2013-04-04       Impact factor: 3.739

Review 10.  NO and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

Authors:  Jian Wang; S Perwez Hussain
Journal:  Antioxid Redox Signal       Date:  2016-09-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.